Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
IM Modlin, M Kidd, I Drozdov, Z-L Siddique & BI Gustafsson. (2008) Pharmacotherapy of neuroendocrine cancers. Expert Opinion on Pharmacotherapy 9:15, pages 2617-2626.
Read now
Read now
Ulf Öhrvall. (1998) Intraoperative Scintigraphic Detection of Abdominal Endocrine Tumors. Upsala Journal of Medical Sciences 103:1, pages 1-34.
Read now
Read now
Articles from other publishers (61)
Rosaria M. Ruggeri, Irene Aini, Stefano Gay, Erika Maria Grossrubatscher, Camilla Mancini, Maria Grazia Tarsitano, Virginia Zamponi, Andrea M. Isidori, Annamaria Colao & Antongiulio Faggiano. (2023) Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors. Reviews in Endocrine and Metabolic Disorders.
Crossref
Crossref
Rosaria M. Ruggeri, Barbara Altieri, Erika Grossrubatcher, Roberto Minotta, Maria Grazia Tarsitano, Virginia Zamponi, Andrea MIsidori, Antongiulio Faggiano & Anna Maria Colao. (2022) Sex differences in carcinoid syndrome: A gap to be closed. Reviews in Endocrine and Metabolic Disorders 23:3, pages 659-669.
Crossref
Crossref
Mohammed B. Allaw, Jeffrey M. Switchenko, Lana Khalil, Christina Wu, Olatunji B. Alese, Mehmet Akce, Amber Draper, Aaron T. Jones, Bassel El-Rayes & Walid Shaib. (2022) Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Oncology 100:3, pages 131-139.
Crossref
Crossref
Krystallenia I. Alexandraki, Kosmas Daskalakis, Marina Tsoli, Ashley B. Grossman & Gregory A. Kaltsas. (2020) Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Trends in Endocrinology & Metabolism 31:3, pages 239-255.
Crossref
Crossref
Robert A. Ramirez, David T. Beyer, Aman Chauhan, J. Philip Boudreaux, Yi-Zarn Wang & Eugene A. Woltering. (2016) The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors. The Oncologist 21:6, pages 671-675.
Crossref
Crossref
Claire K. Mulvey & Emily K. Bergsland. (2016) Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors. Hematology/Oncology Clinics of North America 30:1, pages 63-82.
Crossref
Crossref
Anja Rinke & Sebastian Krug. (2016) Neuroendocrine tumours – Medical therapy: Biological. Best Practice & Research Clinical Endocrinology & Metabolism 30:1, pages 79-91.
Crossref
Crossref
Edward M. Wolin. (2015) Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations. The Oncologist 20:10, pages 1123-1131.
Crossref
Crossref
Mounira Chalabi, Camille Duluc, Philippe Caron, Delphine Vezzosi, Julie Guillermet-Guibert, Stéphane Pyronnet & Corinne Bousquet. (2014) Somatostatin analogs: does pharmacology impact antitumor efficacy?. Trends in Endocrinology & Metabolism 25:3, pages 115-127.
Crossref
Crossref
Cătălina Poiană, Diana Păun & Mara Carsote. (2014) The neuroendocrine markers assay and the glycemia profile in patients with neuroendocrine tumors under octreotide therapy: a 2 years study / Determinarea markerilor neuroendocrini şi a profilului glicemic la pacienţii cu tumori neuroendocrine în tratament cu octreotid. Romanian Review of Laboratory Medicine 22:3.
Crossref
Crossref
Roberta Elisa Rossi, Sara Massironi, Matilde Pia Spampatti, Dario Conte, Clorinda Ciafardini, Federica Cavalcoli & Maddalena Peracchi. (2012) Treatment of Liver Metastases in Patients with Digestive Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 16:10, pages 1981-1992.
Crossref
Crossref
Lucas SidérisPierre DubéAnja Rinke. (2012) Antitumor Effects of Somatostatin Analogs in Neuroendocrine Tumors. The Oncologist 17:6, pages 747-755.
Crossref
Crossref
Tina Zahel, Sabine Krysa, Esther Herpel, Albrecht Stenzinger, Benjamin Goeppert, Peter Schirmacher, Hans Hoffmann, Philipp A. Schnabel & Arne Warth. (2012) Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach. Virchows Archiv 460:3, pages 299-308.
Crossref
Crossref
Anja Rinke, Patrick Michl & Thomas Gress. (2012) Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors. Cancers 4:1, pages 113-129.
Crossref
Crossref
Enrico Ruffini, Alberto Oliaro, Domenico Novero, Paola Campisi & Pier Luigi Filosso. (2011) Neuroendocrine Tumors of the Thymus. Thoracic Surgery Clinics 21:1, pages 13-23.
Crossref
Crossref
Fernando Cirillo. (2018) Role of Somatostatin Analogs in the Management of Neuroendocrine Tumors. Tumori Journal 96:2, pages 191-197.
Crossref
Crossref
I. M. MODLIN, M. PAVEL, M. KIDD & B. I. GUSTAFSSON. (2009) Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Alimentary Pharmacology & Therapeutics 31:2, pages 169-188.
Crossref
Crossref
Mustafa Khasraw, Anthony Gill, Tim Harrington, Nick Pavlakis & Irvin Modlin. (2009) Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis. Journal of Clinical Gastroenterology 43:9, pages 838-847.
Crossref
Crossref
Alexandria T. Phan, James C. Yao & Douglas B. Evans. (2008) Treatment options for metastatic neuroendocrine tumors. Surgery 144:6, pages 895-898.
Crossref
Crossref
Liselot B. J. van Iersel, Ellen J. Hoekman, Hans Gelderblom, Alexander L. Vahrmeijer, Els L. van Persijn van Meerten, Fred G. J. Tijl, Henk H. Hartgrink, Peter J. K. Kuppen, Johan W. R. Nortier, Rob A. E. M. Tollenaar & Cornelis J. H. van de Velde. (2008) Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases. Annals of Surgical Oncology 15:7.
Crossref
Crossref
Simona Grozinsky-Glasberg, Ashley B. Grossman & Márta Korbonits. (2008) The role of somatostatin analogues in the treatment of neuroendocrine tumours. Molecular and Cellular Endocrinology 286:1-2, pages 238-250.
Crossref
Crossref
M. C. Champaneria, I. M. Modlin, I. Latich, J. Bornschein, I. Drozdov & M. Kidd. 2008. Molecular Targeting in Oncology. Molecular Targeting in Oncology
585
637
.
Chandrajit P. Raut, Matthew H. Kulke, Jonathan N. Glickman, Richard S. Swanson & Stanley W. Ashley. (2006) Carcinoid Tumors. Current Problems in Surgery 43:6, pages 391-450.
Crossref
Crossref
Yoshimi Nakajima. (2006) Living-related liver transplantation for multiple liver metastases from rectal carcinoid tumor: A case report. World Journal of Gastroenterology 12:11, pages 1805.
Crossref
Crossref
Pamela Hodul, Mokenge Malafa, Junsung Choi & Larry Kvols. (2017) The Role of Cytoreductive Hepatic Surgery as an Adjunct to the Management of Metastatic Neuroendocrine Carcinomas. Cancer Control 13:1, pages 61-71.
Crossref
Crossref
Willscott E. Naugler & Gordon C. Hunt. 2006. Endoscopic Oncology. Endoscopic Oncology
161
172
.
E. Bajetta, L. Catena, G. Procopio, E. Bichisao, L. Ferrari, S. Della Torre, S. De Dosso, S. Iacobelli, R. Buzzoni, L. Mariani & J. Rosai. (2005) Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?. Annals of Oncology 16:8, pages 1374-1380.
Crossref
Crossref
Tahir Shah & Martyn Caplin. (2005) Biotherapy for metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, pages 617-636.
Crossref
Crossref
Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka & Michael D. Shapiro. (2005) Current Status of Gastrointestinal Carcinoids. Gastroenterology 128:6, pages 1717-1751.
Crossref
Crossref
Niklas Zar, Hans Garmo, Lars Holmberg, Jonas Rastad & Per Hellman. (2004) Long-term Survival of Patients with Small Intestinal Carcinoid Tumors. World Journal of Surgery 28:11, pages 1163-1168.
Crossref
Crossref
Silvia Della Torre, Giuseppe Procopio, Alberto Fusi, Laura Catena, Leonardo Ferrari, Paola Nova, Angela Denaro, Ettore Bichisao & Emilio Bajetta. (2018) Current Treatments of Neuroendocrine Tumors Role of Biotherapy and Chemotherapy. Tumori Journal 89:2, pages 111-116.
Crossref
Crossref
J. Garland, J. R. Buscombe, C. Bouvier, P. Bouloux, M. H. Chapman, A. C. Chow, N. Reynolds & M. E. Caplin. (2003) Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience. Alimentary Pharmacology & Therapeutics 17:3, pages 437-444.
Crossref
Crossref
Joseph M Kaminski, Corey J Langer & Benjamin Movsas. (2003) The role of radiation therapy and chemotherapy in the management of airway tumors other than small-cell carcinoma and non–small-cell carcinoma. Chest Surgery Clinics of North America 13:1, pages 149-167.
Crossref
Crossref
G D Slooter, A Mearadji, W A P Breeman, R L Marquet, M de Jong, E P Krenning & C H J van Eijck. (2001) Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. British Journal of Surgery 88:1, pages 31-40.
Crossref
Crossref
Rabih Chaer, Malek G Massad, Alexander Evans, Norman J Snow & Alexander S Geha. (2002) Primary neuroendocrine tumors of the thymus. The Annals of Thoracic Surgery 74:5, pages 1733-1740.
Crossref
Crossref
H. de Vries, R.C.J. Verschueren, P.H.B. Willemse, I.P. Kema & E.G.E. de Vries. (2002) Diagnostic, surgical and medical aspect of the midgut carcinoids. Cancer Treatment Reviews 28:1, pages 11-25.
Crossref
Crossref
Dermot O'Toole, Michel Ducreux, Gilles Bommelaer, Jean-Louis Wemeau, Olivier Bouch�, France Catus, Jo�lle Blumberg & Philippe Ruszniewski. (2000) Treatment of carcinoid syndrome. Cancer 88:4, pages 770-776.
Crossref
Crossref
B. Eriksson & K. Öberg. (1999) Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook. Annals of Oncology 10, pages S31-S38.
Crossref
Crossref
Kjell Öberg. (1998) Carcinoid Tumors: Current Concepts in Diagnosis and Treatment. The Oncologist 3:5, pages 339-345.
Crossref
Crossref
Shi, Buchanan, Johnston, Larkin, Ong, Ferguson & Laird. (2001)
The octreotide suppression test and [
111
In‐DTPA‐D‐Phe
1
]‐octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment
. Clinical Endocrinology 48:3, pages 303-309.
Crossref
Crossref
B. Eriksson & K. Öberg. 1998. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
766
789
.
ŞuayİB Yalçin, Nurullah Zengİn, Gülten Tekuzman & Türkan Küçükalİ. (1997) Primary neuroendocrine tumor of the breast. Medical Oncology 14:2, pages 121-123.
Crossref
Crossref
JJ Morand, S Lagrassa, R Abitan, MC Koeppel, P Cohen, G Habib, FA Dabeaux-Merger & J Sayag. (1997) Edèmes par fibröses rétropéritonéale et tricuspidienne avec atteinte cutanée sclérodermiforme révélateurs d'une tumeur carcinoïde. À propos d'une observation et revue de la littérature. La Revue de Médecine Interne 18:5, pages 388-395.
Crossref
Crossref
K. Öberg. 1997. Interferons. Interferons
36
46
.
K. Öberg. (1996) Neuroendocrine gastrointestinal tumours. Annals of Oncology 7:5, pages 453-463.
Crossref
Crossref
J.D. CREAMER, S.J. WHITTAKER & W.A.D. GRIFFITHS. (1996) Multiple endocrine neoplasia type 1 presenting as rosacea. Clinical and Experimental Dermatology 21:2, pages 170-171.
Crossref
Crossref
S. Faiss, H. Scherübl, E. O. Riecken & B. Wiedenmann. 1996. New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors. New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors
193
207
.
A. G. HARRIS & J. S. REDFERN. (2007) Octreotide treatment of carcinoid syndrome: analysis of published dose‐titration data. Alimentary Pharmacology & Therapeutics 9:4, pages 387-394.
Crossref
Crossref
L. R. SCHILLER. (2007) Review article: anti‐diarrhoeal pharmacology and therapeutics. Alimentary Pharmacology & Therapeutics 9:2, pages 86-106.
Crossref
Crossref
P. Kogner. 1995. Neuropeptides in the Spinal Cord. Neuropeptides in the Spinal Cord
325
338
.
B. Eriksson & K. Öberg. 1995. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
643
665
.
Kjell Öberg. (1994) Treatment of neuroendocrine tumors. Cancer Treatment Reviews 20:4, pages 331-355.
Crossref
Crossref
KJELL ÖBERG, BARBRO ERIKSSON & EVA TIENSUU JANSON. (1994) The Clinical Use of Interferons in the Management of Neuroendocrine Gastroenteropancreatic Tumors. Annals of the New York Academy of Sciences 733:1 Molecular and, pages 471-478.
Crossref
Crossref
J.H. Donohue. (1994) Malignant tumours of the small bowel. Surgical Oncology 3:2, pages 61-68.
Crossref
Crossref
Rena Vassilopoulou-Sellin & Jaffer Ajani. (1994) Islet Cell Tumors of the Pancreas. Endocrinology and Metabolism Clinics of North America 23:1, pages 53-65.
Crossref
Crossref
Jeffrey A. Norton. (1994) Neuroendocrine tumors of the pancreas and duodenum. Current Problems in Surgery 31:2, pages 89-156.
Crossref
Crossref
Kjell Öberg. (1993) The Use of Chemotherapy in the Management of Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 22:4, pages 941-952.
Crossref
Crossref
Irvin M. Modlin & Marc D. Basson. (1993) Clinical Applications of Gastrointestinal Hormones. Endocrinology and Metabolism Clinics of North America 22:4, pages 823-844.
Crossref
Crossref
B. Eriksson & K. Öberg. 1993. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
299
315
.
Johannes Waltenberger. 1993. Growth Factors and the Cardiovascular System. Growth Factors and the Cardiovascular System
311
320
.
Eva M.Tiensuu Janson, Håkan Ahlström, Torbjörn Andersson & Kjell E. Öberg. (1992) Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours. European Journal of Cancer 28:10, pages 1647-1650.
Crossref
Crossref